Otrivine Adult Menthol (Xylometazoline Hydrochloride)

Xylometazoline is an alpha‑adrenergic agonist. When applied to the nasal mucosa, it stimulates peripheral alpha‑1 receptors, causing vasoconstriction of the small blood vessels. This reduces mucosal edema and limits fluid exudation, leading to a rapid decrease in nasal obstruction and easier breathing.

The exact dosing regimen for Otrivine Adult Menthol is determined by the prescribing healthcare professional. Typically, adults are instructed to spray a specified number of sprays per nostril, not exceeding the recommended maximum daily frequency, and to limit treatment to a few days to avoid rebound congestion.

Safety data for xylometazoline during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their physician. The prescriber will weigh potential benefits against any possible risks to the mother and infant before recommending the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details and any necessary import documentation.

Both xylometazoline and oxymetazoline belong to the imidazoline class and act as alpha‑adrenergic agonists, providing similar rapid decongestion. Xylometazoline may have a slightly longer duration of action, but both share comparable safety profiles and the same risk of rebound congestion if used beyond the recommended period.

Store the nasal spray at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture and direct sunlight, and store it out of reach of children. Do not freeze the product.

Otrivine Adult Menthol is administered as a topical intranasal spray. The user gently inserts the nozzle into each nostril and delivers the prescribed number of sprays, usually one to two per nostril, while inhaling gently. The spray should be used only as directed by a healthcare professional.

Serious adverse events, although rare, include severe hypertension, arrhythmias, nasal ulceration, epistaxis, and anaphylactic reactions. Prolonged use beyond three to five days can cause rebound nasal congestion (rhinitis medicamentosa). Patients should seek immediate medical attention if they experience chest pain, rapid heartbeat, severe headache, or signs of an allergic reaction.

The product should be avoided by individuals with known hypersensitivity to xylometazoline or any excipients, patients with severe hypertension or cardiovascular disease, children under 12 years of age, and anyone using monoamine oxidase inhibitors or other topical nasal decongestants without medical advice.